Biotech

All Articles

Ideaya bags choice on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is actually wagering $400 million in biobucks that a bispecific antibody-drug co...

Takeda takes $140M loss on stopped working epilepsy drug, promotes FDA run

.Our experts actually recognize that Takeda is actually hoping to locate a path to the FDA for epile...

VBI Vaccines files for bankruptcy, looks for resource sale

.Immunology biotech VBI Vaccines is veering alarmingly near to the point of no return, along with pr...

Celldex anti-cKIT antitoxin reduce hives in another stage 2 research study

.It's difficult to muscle mass in on a space as very competitive as immunology, but Celldex Therapie...

Boehringer provides to $1.3 B for checkpoint prevention biotech

.Boehringer Ingelheim is offering up to $1.3 billion for Nerio Therapeutics as well as a preclinical...

Ventyx's last resort for inflammatory med ends in Crohn's failure

.Ventyx Biosciences' Crohn's condition medication performed certainly not assist clients attain remi...

Cognition's stage 2 SHINE records stain Alzheimer's prospect

.Cognition Therapeutics' stage 2 luster trial has actually taken several of the appeal off the Alzhe...

BMS axes bispecific months after submitting to function stage 3 test

.Bristol Myers Squibb has actually possessed a whiplash change of mind on its own BCMA bispecific T-...

Charles Baum takes control of Terremoto as CEO

.Charles Baum, M.D., Ph.D., who managed Mirati Therapeutics' $ 5.8 billion purchase to Bristol Myers...

Asarina to shut after attempts to partner Tourette's medication neglect

.After communicating to much more than 200 providers to partner a Tourette disorder treatment that p...